The current valuation score of Mirum Pharmaceuticals Inc is 9.66, ranking 7 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is -7.80, which is -38.60% below the recent high of -4.79 and -2934.17% above the recent low of -236.52.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.